Bilousova Ganna, Roop Dennis R
Department of Dermatology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045 Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045.
Cold Spring Harb Perspect Med. 2014 Nov 3;4(11):a015164. doi: 10.1101/cshperspect.a015164.
The discovery of methods for reprogramming adult somatic cells into induced pluripotent stem cells (iPSCs) has raised the possibility of producing truly personalized treatment options for numerous diseases. Similar to embryonic stem cells (ESCs), iPSCs can give rise to any cell type in the body and are amenable to genetic correction by homologous recombination. These ESC properties of iPSCs allow for the development of permanent corrective therapies for many currently incurable disorders, including inherited skin diseases, without using embryonic tissues or oocytes. Here, we review recent progress and limitations of iPSC research with a focus on clinical applications of iPSCs and using iPSCs to model human diseases for drug discovery in the field of dermatology.
将成人体细胞重编程为诱导多能干细胞(iPSC)的方法的发现,为众多疾病提供真正个性化治疗方案带来了可能性。与胚胎干细胞(ESC)相似,iPSC可以分化为体内任何细胞类型,并且可通过同源重组进行基因校正。iPSC的这些ESC特性使得无需使用胚胎组织或卵母细胞,就能开发针对许多目前无法治愈的疾病(包括遗传性皮肤病)的永久性矫正疗法。在此,我们综述了iPSC研究的最新进展和局限性,重点关注iPSC的临床应用以及利用iPSC建立人类疾病模型用于皮肤病学领域的药物发现。